You are here: Home » Companies » News
Business Standard

J&J loses motion to overturn $4.7 billion talc-ovarian cancer verdict

The motion was aimed at getting a verdict that awarded $4.7 bn to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products reversed

Reuters 

Healthcare conglomerate Johnson & Johnson has lost its motion to reverse a verdict that awarded $4.7 billion to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products, a Missouri court ruled on Wednesday.     ALSO READ: J&J says talc powder in India safe, drug regulators visited plants  Shares of the company reversed course to slip 0.6 per cent to $129.38 in afternoon trading.  

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, December 19 2018. 23:37 IST
RECOMMENDED FOR YOU